1. Home
  2. XERS vs MNRO Comparison

XERS vs MNRO Comparison

Compare XERS & MNRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • MNRO
  • Stock Information
  • Founded
  • XERS 2005
  • MNRO 1957
  • Country
  • XERS United States
  • MNRO United States
  • Employees
  • XERS N/A
  • MNRO N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • MNRO Automotive Aftermarket
  • Sector
  • XERS Health Care
  • MNRO Consumer Discretionary
  • Exchange
  • XERS Nasdaq
  • MNRO Nasdaq
  • Market Cap
  • XERS 628.7M
  • MNRO 658.9M
  • IPO Year
  • XERS 2018
  • MNRO 1991
  • Fundamental
  • Price
  • XERS $5.01
  • MNRO $12.22
  • Analyst Decision
  • XERS Strong Buy
  • MNRO Buy
  • Analyst Count
  • XERS 6
  • MNRO 4
  • Target Price
  • XERS $6.25
  • MNRO $20.75
  • AVG Volume (30 Days)
  • XERS 2.2M
  • MNRO 686.1K
  • Earning Date
  • XERS 05-08-2025
  • MNRO 05-22-2025
  • Dividend Yield
  • XERS N/A
  • MNRO 9.12%
  • EPS Growth
  • XERS N/A
  • MNRO N/A
  • EPS
  • XERS N/A
  • MNRO 0.62
  • Revenue
  • XERS $222,551,000.00
  • MNRO $1,210,419,000.00
  • Revenue This Year
  • XERS $31.75
  • MNRO N/A
  • Revenue Next Year
  • XERS $21.09
  • MNRO $2.89
  • P/E Ratio
  • XERS N/A
  • MNRO $19.91
  • Revenue Growth
  • XERS 29.88
  • MNRO N/A
  • 52 Week Low
  • XERS $1.72
  • MNRO $13.50
  • 52 Week High
  • XERS $6.07
  • MNRO $31.49
  • Technical
  • Relative Strength Index (RSI)
  • XERS 59.63
  • MNRO 26.08
  • Support Level
  • XERS $4.26
  • MNRO $13.53
  • Resistance Level
  • XERS $5.28
  • MNRO $14.40
  • Average True Range (ATR)
  • XERS 0.28
  • MNRO 0.53
  • MACD
  • XERS 0.09
  • MNRO -0.10
  • Stochastic Oscillator
  • XERS 78.91
  • MNRO 0.85

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About MNRO Monro Inc.

Monro Inc is a provider automobile service stations in the United States. Through its network of company-owned service stations, Monro Muffler Brake offers maintenance, repair, tire, and fleet management services for automobiles focused largely on undercar services such as brake, steering, exhaust, drivetrain, and suspension systems. Next to service stores, the company also offers tire stores specialised in tire replacement and service.

Share on Social Networks: